Prostate cancer: Diagnostic value of dynamic contrast-enchanced MRI, diffusion weighted imaging and 3D 1H-MR spectroscopy

Chinese Journal of Radiology

Volumn 40, Issue 7, 2006, Pages 678-683

  Shi, Hao ^a   Wu, Le Bin ^a   Ding, Hong Yu ^a   Zhao, Bin ^a   Wang, Tao ^a   Yang, Zhen Zhen ^a   Qiu, Xiu Ling ^a   Li, Hui Hua ^a   Qu, Lei ^a   Wei, Yu Long ^a  

^a Department of MR Shandong Medical Imaging Research Institute ^*  (China)

Author keywords

Magnetic resonance imaging; Prostatic hyperplasia; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; THREE DIMENSIONAL IMAGING;

EID: 33748598276     PISSN: 10051201     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol, 2000, 55: 99-109.
2. Chinese source. 2002,18:598-601.
3. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging,2002,16:196-200.
4. Ertem K, Alkan A, Sarac K, et al. Magnetic resonance spectroscopy study of proton metabolite level changes in sensorimotor cortex after upper limb replantation-revascularization. Magn Reson Imaging, 2005,23:105-109.
5. Jacobs MA, Barker PB, Argani P, et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging,2005,21:23-28.
6. Chinese source. 2005,39:50-53.
7. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging,2004,20:654-661.
8. Butts K, Daniel BL, Chen L, et al. Diffusion-weighted MRI after cryosurgery of the canine prostate, magnetic resonance imaging. J Magn Reson Imaging,2003,17:131-135.
9. Kurhanewicz J, Swanson MG, Nelson SJ, et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging, 2002, 16: 451-463.
10. Turnbull LW, Buckley DL, Turnbull LS, et al. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic GD-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging, 1999,9:311-316.
11. Aboagye EO, Bhujwalla ZM. Malignant thansformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res, 1999,59:80-84.
12. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at enderectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology, 2004,233:701-708.
13. Liney GP, Turnbull LW, Knosles AJ. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed, 1999,12:39-44.